Correlation Between Microsoft and Erytech Pharma
Can any of the company-specific risk be diversified away by investing in both Microsoft and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Erytech Pharma SA, you can compare the effects of market volatilities on Microsoft and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Erytech Pharma.
Diversification Opportunities for Microsoft and Erytech Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Microsoft and Erytech is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Microsoft i.e., Microsoft and Erytech Pharma go up and down completely randomly.
Pair Corralation between Microsoft and Erytech Pharma
If you would invest (100.00) in Erytech Pharma SA on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Erytech Pharma SA or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Microsoft vs. Erytech Pharma SA
Performance |
Timeline |
Microsoft |
Erytech Pharma SA |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Microsoft and Erytech Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Microsoft and Erytech Pharma
The main advantage of trading using opposite Microsoft and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Adobe Systems Incorporated | Microsoft vs. Crowdstrike Holdings |
Erytech Pharma vs. Genfit | Erytech Pharma vs. HCW Biologics | Erytech Pharma vs. Aptorum Group Ltd | Erytech Pharma vs. Surrozen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |